Orchestra Biomed Holdings, Inc. (HSAQ) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

CareDx, Inc.

Tactile Systems Technology, Inc.

Organogenesis Holdings, Inc.

Pulmonx Corp.

Surmodics, Inc.

Utah Medical Products, Inc.

Nano-X Imaging Ltd.

CVRx, Inc.

Orchestra Biomed Holdings, Inc.

AirSculpt Technologies, Inc.

OraSure Technologies, Inc.

Why is Orchestra Biomed Holdings, Inc. ?

Negative results in Sep 25

INTEREST(9M) At USD 0.52 MM has Grown at inf%
OPERATING CASH FLOW(Y) Lowest at USD -60.24 MM
OPERATING PROFIT(Q) Lowest at USD -20.23 MM

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 14.57%, its profits have fallen by -33.7%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Orchestra Biomed Holdings, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Orchestra Biomed Holdings, Inc.

17.53%

-0.48

87.14%

S&P 500

14.9%

0.77

19.29%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

39.80%

EBIT Growth (5y)

-393.14%

EBIT to Interest (avg)

-36.76

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-2.07

Sales to Capital Employed (avg)

0.06

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

45.68%

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

6.09

EV to EBIT

-2.68

EV to EBITDA

-2.69

EV to Capital Employed

-9.59

EV to Sales

71.51

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-171.70%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Mildly Bearish

Mildly Bullish

Dow Theory

Mildly Bearish

OBV

No Trend

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company

NET PROFIT(HY)

Higher at USD -40.19 MM

RAW MATERIAL COST(Y)

Fallen by 0.6% (YoY

EPS(Q)

Highest at USD -0.4

-19What is not working for the Company

INTEREST(9M)

At USD 0.52 MM has Grown at inf%

OPERATING CASH FLOW(Y)

Lowest at USD -60.24 MM

OPERATING PROFIT(Q)

Lowest at USD -20.23 MM

PRE-TAX PROFIT(Q)

Lowest at USD -20.83 MM

NET PROFIT(Q)

Lowest at USD -20.83 MM

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.62 times

Here's what is working for Orchestra Biomed Holdings, Inc.

EPS

Highest at USD -0.4

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Raw Material Cost

Fallen by 0.6% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Orchestra Biomed Holdings, Inc.

Interest

At USD 0.52 MM has Grown at inf%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Operating Cash Flow

Lowest at USD -60.24 MM and Fallen

In each year in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Operating Profit

Lowest at USD -20.23 MM and Fallen

In each period in the last five periods

MOJO Watch

Near term Operating Profit trend is quite negative

Operating Profit (USD MM)

Pre-Tax Profit

Lowest at USD -20.83 MM and Fallen

In each period in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (USD MM)

Net Profit

Lowest at USD -20.83 MM and Fallen

In each period in the last five periods

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (USD MM)

Pre-Tax Profit

At USD -20.83 MM has Fallen at -19.53%

over average net sales of the previous four periods of USD -17.42 MM

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Inventory Turnover Ratio

Lowest at 1.62 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio